Alex Konstantinidis

Director of Cmc Program Management @Alexion Pharmaceuticals, Inc.

Chicago, IL, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2021 — Present

Director of Cmc Program Management @Alexion Pharmaceuticals, Inc.

View department →

Lead 3 CMC cross functional teams for Rare Disease biologic programs. Represented CMC team in the GPT, where I aligned the GPT clinical requirements and timelines with the program strategy- Late stage biologic (Enzyme Replacement Therapy) product development to Ph 3 under highly accelerated timelines- Combination product development of a biologic (VHH) in Autoinjector currently in Ph 2- Early stage biologic program development in non-clinical stage (Phase 1 IND expected in 1H24).

SKILLS

LyophilizationGmpClinical TrialsMicrobiologyVaccinesTechnology TransferProtein ChemistryHplcCellPharmaceutical IndustryCell BiologyR&DVaccine DevelopmentBiochemistryDrug DevelopmentCompetitive AnalysisTechnology TraBiopharmaceuticalsStrategic PlanningProtein PurificationFda SubmissionsHigh Throughput ScreeningClinical DevelopmentAssay DevelopmentMolecular BiologyDrug DiscoveryLeadershipOncologyMedicinal ChemistryFormulationCommercialization

ABOUT ALEX KONSTANTINIDIS

Extensive business and technical experience in leading organizations, managing complex…

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.